Skip to main content

December 2016

 

 

academics

 

Clinical research courses

Career for Pharmacist(03 posts) in Office of Superintendent at VSS Institute of Medical Sciences and Research

Applications are invited for the following posts in tne prescribed proforma given below for selection and appointment to the post on contractual basis in VSS Institute of Medical Sciences and Research. Burla.PIN:768017 in the District of Sambalpur through Speed post/Regd.Post only so as to reach the office of the undersigned or. on before 09.01.2017. Application received after the due date shall not be considered under any circumstances.

Opportunity in Operations for B.Pharm, D.Pharm as Officer at HLL Lifecare

HLL Lifecare Limited is a Mini Ratna Company of Govt. of India under the Ministry of Health & Family Welfare. HLL, a Schedule-B Public Sector Enterprise is today a multi product, multi unit organization addressing various public health challenges. The Company with seven manufacturing units and marketing offices throughout the country is engaged in the manufacturing and marketing of a wide range of contraceptives and healthcare products. The company has also ventured into Infrastructure Development, Procurement & Consultancy Services, setting up of Life Spring Hospitals, Women's Health Pharma Division and setting up of Diagnostic Centres.

Post:  OFFICER (OPERATIONS)

Work in Quality Assurance at Sun Pharma | walk in

Sun Pharma an international,specialty pharmaceutical company headquartered in India with a global manufacturing network across 25 countries. We manufacture and market a large basket of pharmaceutical formulations as branded generics & generics in India, US and across the world. Our leadership is approachable, encourages transparency & strong work ethics to ensure that people get the best opportunities to learn and grow. We encourage our employees to challenge themselves for highest level of performance through greater bandwidth of work responsibilities and growth opportunities. Apply to us if you wish to be part of Sun Pharma growth story.

Post : QUALITY ASSURANCE (NON OSD FORMULATIONS)

Job for Senior Analyst - Clinical Coding at Novartis | Degree in Life science, Pharmacy

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Senior Analyst - Clinical Coding

Vacancy for Manager at Biological E Limited

Biological E Limited is the first pharmaceutical company to manufacture anti TB drugs in India.Celebration is a way through which humanity expresses its fondness for life. At Biological E. Limited, we express this fondness through our continuous efforts to make disease prevention a distinct reality, with the recent genealogical innovations and mankind's ability to predict illness.

Post : Mfg.Science (Adjuvants), Manager

Work as Brand Manager (Dermatology) in Start-up Pharma Co.

Our client is an innovative and vibrant company in the field of health-care. The company, in its four years since foundation, has achieved many successful alliances with global partners footprints outside of India. The company is driven by objective of bringing innovative healthcare products to the country.

Post: Group Product Manager - 01 post

Vacancy for Corporate Quality Assurance - Solid dosage in Evolet Healthcare

Evolet Healthcare Pvt. Ltd. is an international, modern and dynamic outsourcing company that specializes in the field of contract manufacturing and marketing of pharmaceutical products. The Management of the company constantly monitors innovations in the pharmaceutical industry to keep up with the ever-increasing demands on pharmaceutical products to improve and enhance the quality of services irrespective of which part of the world the client comes from.
Evolet Healthcare Pvt. Ltd. has long-term contracts with manufacturers of pharmaceutical products, as well as with international pharmaceutical corporations and marketing companies that distribute its products in the markets of Asia, EU, CIS, Africa and Latin America.
Evolet Healthcare is into contract manufacturing of pharmaceutical products.We are based in Gurgaon, NCR

Post: Corporate Quality Assurance- Solid dosage

COMPARATIVE DIURETIC STUDY OF MEDICINAL PLANTS IN IDIVIDUAL AND COMBINATION FORM

{ DOWNLOAD AS PDF }

ABOUT AUHTOR
Babar Vishal Bharat.*

Dattakala College of Pharmacy (D. Pharmacy),
Pune,Maharashtra, India
*vishalbabar@gmail.com

ABSTRACT:
In the present study, the hydroalcoholic extracts of Nycatanthes arbortristis Linn. (Parijatha) and Hygrophila spinosa T. Anders (Kokila) and combination of these extracts were compared for their diuretic activity using Lipschitz test. Standard drug used was furosemide (100mg/kg body weight) in 0.9% sodium chloride solution. All the extracts significantly increased urine elimination and Na+, K+, and Cl- excretion as compared to normal saline treated groups. The combination of hydroalcoholic extracts of Nycatanthes arbortristis and Hygrophila spinosa in 1:1 ratio showed better diuretic activity. Comparatively the hydroalcoholic extracts of Nycatanthes arbortristis showed more significant activity than Hygrophila spinosa extracts. The result revealed that Nycatanthes arbortristis is having better diuretic activity than Hygrophila spinosa which supports the traditional use of the plant.

Loxo Oncology, Inc.,a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers,  announced a comprehensive program update for larotrectinib (LOXO-101), a selective inhibitor of tropomyosin receptor kinase (TRK), and its pipeline drug candidates, LOXO-292 and LOXO-195.

Clovis Oncology, Inc.  announced that the U.S. Food and Drug Administration (FDA) has approved Rubraca™ (rucaparib) tablets as monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer, who have been treated with two or more chemotherapies, and selected for therapy based on an FDA-approved companion diagnostic for Rubraca.